Bristol-Myers Squibb Cancer Drug Shows Promise
publication date: Jun 4, 2012
A new drug that shrinks tumors in lung cancer patients exemplifies Bristol-Myers' aggressive cancer treatment pipeline. However, we think its stock is expensive at current levels.
To gain access to the members only content, click here to subscribe.
You will be given immediate access to premium content on the site.